United States · FDA National Drug Code directory
GAVILYTE G TM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43386-090_896fc5ca-9a67-47c1-a317-f8dd4a3654c8
- Product NDC
- 43386-090
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- polyethylene glycol-3350 and Electrolytes
- Labeler
- Lupin Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090601
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 236 g/274.31g
- SODIUM SULFATE ANHYDROUS — 22.74 g/274.31g
- SODIUM BICARBONATE — 6.74 g/274.31g
- SODIUM CHLORIDE — 5.86 g/274.31g
- POTASSIUM CHLORIDE — 2.97 g/274.31g
These values do not establish equivalence or a dose recommendation.
Packages
- 274.31 g in 1 BOTTLE (43386-090-19) · 43386-090-19
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →